Refine by
Diagnostics Introduces Elisa Kit Development Suppliers Serving Aruba
118 companies found
based inBerlin, GERMANY
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high ...
based inBurlingame, CALIFORNIA (USA)
Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis. This test has not yet been ...
based inShirley, CALIFORNIA (USA)
STEMart is an industry-leading eCommerce platform, with an expanded global footprint, we now have a broad portfolio of more than 10,000 products. In the fields of science, technology, and engineering, from the discovery stage towards the ...
based inSeongnam-si, SOUTH KOREA
OPTOLANE is a semiconductor based In-Vitro diagnostic platform company that develops diagnostic systems with high sensitivity. The company is specialized in “Digital Real-Time PCR” system which can operate as both Real-Time PCR and Digital PCR. This ...
based inBurnaby, BRITISH COLUMBIA (CANADA)
Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify disease ...
based inEureka, CALIFORNIA (USA)
S-Matrix develops advanced and innovative Quality by Design software. S-Matrix has changed our product name from Fusion AE to Fusion QbD® as an acknowledgement of our commitment to developing software that is 100% aligned with Quality by Design ...
based inLund, SWEDEN
AcouSort is an innovative technology company with high focus on products and solutions for automated preparation of biological samples for researchers and life science companies. The core technology is acoustofluidics where a combination of ...
based inOr Akiva, ISRAEL
Innoventions is a privately held medical device development company and functions as a privately held technology accelerator/incubator dedicated to the development of Prof. Daniel Yachia and his team’s medical device ideas and inventions. We develop ...
based inSaint Paul, MINNESOTA (USA)
Since 1977, we’ve been dedicated to cardiorespiratory health solutions. Headquartered in Saint Paul, Minnesota, USA, MGC Diagnostics Corporation, develops, manufactures and markets non-invasive diagnostic systems for detecting, classifying and ...
based inIstanbul, TURKEY
Archem Diagnostics; Our main focus is IVD reagents manufacturing and marketing. Having started its operations in 1998, Archem Diagnostics is one of the well-established biochemistry and hematology reagents manufacturer companies in Turkey. Our ...
based inSarasota, FLORIDA (USA)
Lumos Diagnostics specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test solutions to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and ...
based inYokohama, JAPAN
We provide a unique combination of services and products to power your translational research. With scientists and laboratories on three continents, REPROCELL has the scientific and clinical expertise to better translate your discoveries into ...
based inPeachtree Corners, GEORGIA (US) (USA)
Guided Therapeutics, Inc. (OTC: QB GTHP) is committed to developing groundbreaking medical devices using our patented biophotonic technology to detect diseases earlier, more accurately, and more efficiently than other tests. Since Guided ...
Our patented technology, which features our flagship product the LuViva® Advanced Cervical Scan, uses biophotonics to detect both physical and chemical changes in tissues that are early signs of cancer. ...
based inMinneapolis, MINNESOTA (USA)
For more than 50 years, ARKRAY has developed innovative diagnostic and monitoring products including automated systems for urinalysis, A1C, clinical chemistry instruments, reagents and consumables. In addition, ARKRAY is a leader in the blood ...
based inSingapore, SINGAPORE
X-ZELL is fusing multi-channel immunostaining with digital single-cell imaging technology to enable same-day cancer diagnoses from minimally invasive body liquids – ready for routine cytology. X-ZELL is an award-winning medical technology company ...
based inGuangdong, CHINA
Fapon Biotech Inc., founded in 2001, adheres to the mission of “Enable Disease Identification Earlier, More Accurate, Convenient and Affordable”, while focusing on the future needs and trends of biotechnology development, and committed to providing ...
based inBerlin, GERMANY
Adrenomed AG is a privately-financed, clinical-stage biopharmaceutical company with a clear mission: developing precision medicine to rescue vascular integrity and saving the lives of critically ill patients with limited treatment options. The ...
based inWijchen, NETHERLANDS
Future Diagnostics is the obvious choice for in vitro diagnostic (IVD) assay development – for start-ups, mid-sized biotech companies and multinationals in the global IVD medical device market. With 20+ years of expert experience and 150 IVD ...
based inNewark, CALIFORNIA (USA)
ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and ...
There is growing interest in RNA-based biomarkers and measuring RNA expression holds great promise for stratifying patients based on drug response, drug efficacy and risk of side effects. RNAscope in situ hybridization enables molecular detection in ...
